Full Text
EE597 Budget Impact Analysis of Introducing Benralizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: A European Perspective

Abstract

Authors

D Booth J Silvanto J Persson

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×